A PHASE-II TRIAL OF DEOXYSPERGUALIN IN RECURRENT SQUAMOUS-CELL HEAD AND NECK-CANCER

被引：2
|
作者：
PFISTER, DG
BAJORIN, D
MOTZER, RJ
SCHER, H
LOUISON, C
HARRISON, L
SHAH, J
STRONG, E
BOSL, G
机构：
[1] MEM SLOAN KETTERING CANC CTR,DEPT RADIAT ONCOL,BRACHYTHERAPY SERV,NEW YORK,NY 10021
[2] MEM SLOAN KETTERING CANC CTR,DEPT MED,HEAD & NECK SURG SERV,NEW YORK,NY 10021
[3] CORNELL UNIV,MED CTR,COLL MED,DEPT MED,NEW YORK,NY 10021
[4] CORNELL UNIV,MED CTR,COLL MED,DEPT RADIOL,NEW YORK,NY 10021
[5] CORNELL UNIV,MED CTR,COLL MED,DEPT SURG,NEW YORK,NY 10021
来源：
INVESTIGATIONAL NEW DRUGS | 1993年 / 11卷 / 01期
关键词：
DEOXYSPERGUALIN; HEAD AND NECK CANCER;
D O I：
10.1007/BF00873911
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Fifteen patients with recurrent squamous cell head and neck cancer were treated with deoxyspergualin. There were no objective responses in 14 evaluable patients. The most common toxicity was reversible hypotension, which prompted dose reduction in nine patients. Deoxyspergualin is not recommended for the treatment of squamous cell head and neck cancer.
引用
收藏
页码：53 / 56
页数：4
相关论文
共 50 条
  • [1] PHASE-II TRIAL OF N-METHYLFORMAMIDE (NMF) IN SQUAMOUS-CELL HEAD AND NECK-CANCER
    VOGEL, WC
    FORASTIERE, AA
    TAKASUGI, B
    NATALE, RB
    SCHNUR, G
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 91 - 91
  • [2] PHASE-II TRIAL OF TIAZOFURIN IN RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    DIMERY, IW
    NEIDHART, JA
    MCCARTHY, K
    KRAKOFF, IH
    HONG, WK
    CANCER TREATMENT REPORTS, 1987, 71 (04): : 425 - 426
  • [3] PHASE-II STUDY OF ORAL MILTEFOSINE IN PATIENTS WITH SQUAMOUS-CELL HEAD AND NECK-CANCER
    VERWEIJ, J
    GANDIA, D
    PLANTING, AST
    STOTER, G
    ARMAND, JP
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (05) : 778 - 779
  • [4] PHASE-II TRIAL OF VINDESINE IN ADVANCED SQUAMOUS-CELL CANCER OF THE HEAD AND NECK
    VOGL, SE
    CAMACHO, FJ
    KAPLAN, BH
    ODONNELL, MR
    CANCER TREATMENT REPORTS, 1984, 68 (03): : 559 - 560
  • [5] PHASE-II TRIAL OF VINDESINE IN PATIENTS WITH SQUAMOUS-CELL CANCER OF THE HEAD AND NECK
    SLEDGE, GW
    CLARK, GM
    GRIFFIN, C
    MATTOX, DE
    VONHOFF, DD
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (03): : 209 - 211
  • [6] PHASE-II TRIAL OF IFOSFAMIDE IN RECURRENT AND METASTATIC HEAD AND NECK-CANCER
    BUESA, JM
    FERNANDEZ, R
    ESTEBAN, E
    ESTRADA, E
    BARON, FJ
    PALACIO, I
    GRACIA, M
    LACAVE, AJ
    ANNALS OF ONCOLOGY, 1991, 2 (02) : 151 - 152
  • [7] PHASE-II TRIAL OF MITOGUAZONE IN PATIENTS WITH RECURRENT HEAD AND NECK-CANCER
    CONINX, P
    NASCA, S
    JEZEKOVA, D
    ROELANDT, H
    MOREL, M
    LEGROS, M
    CATTAN, A
    BULLETIN DU CANCER, 1985, 72 (02) : 153 - 154
  • [8] EPIRUBICIN, METHOTREXATE AND BLEOMYCIN IN THE MANAGEMENT OF RECURRENT SQUAMOUS-CELL HEAD AND NECK-CANCER - A GSTTC RANDOMIZED PHASE-II STUDY
    PACCAGNELLA, A
    PAPPAGALLO, GL
    SEGATI, R
    ZORAT, P
    CAVANIGLIA, G
    LUNGHI, F
    MIGLIORINI, V
    FRATTINA, A
    BIANCO, A
    SILENI, VC
    AVERSA, SML
    FAVARETTO, A
    VINANTE, O
    FIORENTINO, MV
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (05) : 704 - 708
  • [9] PHASE-II TRIAL OF MITOXANTRONE IN HEAD AND NECK-CANCER
    AAPRO, MS
    ALBERTS, DS
    INVESTIGATIONAL NEW DRUGS, 1984, 2 (03) : 329 - 330
  • [10] PHASE-II TRIAL OF CARBOPLATIN PLUS CISPLATIN IN RECURRENT AND ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    DIMERY, IW
    BROOKS, BJ
    WINN, R
    MARTIN, T
    SHIRINIAN, M
    HONG, WK
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (11) : 1939 - 1944
12345